Plain-English translation of NCT07318155 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called that is given as an injection under the skin. The trial will enroll about 104 people with chronic coronary artery disease (narrowed heart arteries) and/or peripheral arterial disease (narrowed leg arteries) to see how safe the medication is and how well it works in the body. Participants will receive different doses of the medication or a placebo (inactive injection) while continuing their regular aspirin therapy.
Coronary and peripheral artery diseases affect millions of people and increase the risk of heart attack and stroke. Researchers are testing this new medication to see if it can help improve blood flow and reduce complications in people living with these conditions.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either one of four different doses of the medication or a placebo, all given as injections under the skin. The study is double-blind, meaning neither you nor the researchers will know which treatment you're receiving. You will have multiple visits to the research clinic where they will monitor how the medication affects your body through blood tests and other safety checks, and track any side effects you experience.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China